Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor

International Journal of Cancer

Volumn 92, Issue 5, 2001, Pages 748-755

  Houimel, Mehdi ^b   Schneider, Pascal ^b   Terskikh, Alexei ^a   Mach, Jean Pierre ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Anti proliferation; ErbB 2; Peptabody; Peptide; Phage display

Indexed keywords

GROWTH FACTOR RECEPTOR; HEXAPEPTIDE; MONOCLONAL ANTIBODY; ONCOPROTEIN; RECOMBINANT PROTEIN;

ARTICLE; BREAST ADENOCARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR INTERACTION; OVARY ADENOCARCINOMA; PEPTIDE SYNTHESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDE LIBRARY; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0035371932     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010601)92:5<748::AID-IJC1258>3.0.CO;2-1     Document Type: Article

References (45)

1. Synergistic interaction of p185/c-Neu and the EGF receptor leads to transformation of rodent fibroblasts
2. The Neu gene: An ErbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor
3. Studies of the HER-2/Neu proto-oncogene in human breast and ovarian cancer
4. Monoclonal antibodies against the extracellular domain of the ErbB-2 receptor function as partial ligand agonists
5. P185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor
6. A target for tumour-directed therapy
7. Therapy of an animal model of human gastric cancer using a combination of anti-ErbB-2 monoclonal antibodies
8. Mechanistic aspects of the opposing effects of monoclonal antibodies to the ErbB-2 receptor on tumor growth
9. Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with her2/neu gene amplification
10. Phase II study of weekly intravenous recombinant humanized anti-p185/HER2 monoclonal antibody in patients with HER2/Neu-overexpressing metastatic breast cancer
11. Humanization of an anti-p185HER2 antibody for human cancer therapy
12. Characterization of a growth factor that binds exclusively to the ErbB- 2 receptor and induces cellular responses
13. Direct interaction of a ligand for the ErbB-2 oncogene product with the EGF receptor and p185ErbB-2
14. An intramembrane modulator of the ErbB-2 receptor tyrosine kinase that potentiates neuregulin signaling
15. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
16. Requirement for neuregulin receptor ErbB-2 in neural and cardiac development
17. The neu-oncogene: Signal transduction pathways, transformation mechanisms and evolving therapies
18. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
19. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the map kinase pathway
20. Heterodimerization of the ErbB-1 and ErbB-2 receptors in human breast carcinoma cells: A mechanism for receptor transregulation
21. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer
22. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations
23. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions
24. The cellular response to neuregulins is governed by complex interactions of the ErbB receptor family
25. Small peptides as potent mimetics of the protein hormone erythropoietin
26. Libraries of peptides and proteins displayed on filamentous phage
27. The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residues 20 and 83
28. Characterization of human and mouse cartilage oligomeric matrix protein
29. "Peptabody": A new type of high avidity binding protein
30. New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries
31. Bivalence of EGF-like ligands drives the ErbB signaling network
32. Characterization of Fas (APO-1, CD95)-Fas ligand interaction
33. Experiments in molecular genetics
34. Isolation of high affinity human antibodies directly from large synthetic repertoires
35. By-passing immunization: Human antibodies from V-gene libraries displayed on phage
36. Solid phase synthesis. Nobel Lecture, 8 December 1984
37. Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes
38. The normal ErbB-2 product is an atypical receptor-like tyrosine kinase
39. Cooperative signaling of ErbB-3 and ErbB-2 in neoplastic transformation and human mammary, carcinomas
40. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling
41. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors
42. Peptide agonist of the thrombopoietin receptor as potent as the natural
43. Functional mimicry of a protein hormone by a peptide agonist: The EPO
44. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with Neu oncogene
45. Rationally designed anti-HER2/Neu peptide mimetic disables p185HER2/Neu